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The fragile X-related disorders are members of the Repeat Expansion Diseases, a group
of genetic conditions resulting from an expansion in the size of a tandem repeat tract at
a specific genetic locus. The repeat responsible for disease pathology in the fragile X-
related disorders is CGG/CCG and the repeat tract is located in the 50 UTR of the FMR1
gene, whose protein product FMRP, is important for the proper translation of dendritic
mRNAs in response to synaptic activation. There are two different pathological FMR1
allele classes that are distinguished only by the number of repeats. Premutation alleles
have 55–200 repeats and confer risk of fragile X-associated tremor/ataxia syndrome and
fragile X-associated primary ovarian insufficiency. Full mutation alleles on the other hand
have >200 repeats and result in fragile X syndrome, a disorder that affects learning and
behavior. Different symptoms are seen in carriers of premutation and full mutation alleles
because the repeat number has paradoxical effects on gene expression: Epigenetic
changes increase transcription from premutation alleles and decrease transcription from
full mutation alleles. This review will cover what is currently known about the mechanisms
responsible for these changes in FMR1 expression and how they may relate to other
Repeat Expansion Diseases that also show repeat-mediated changes in gene expression.
Keywords: fragile X-associated tremor/ataxia syndrome, fragile X-associated primary ovarian insufficiency, fragile
X syndrome, Repeat-mediated gene silencing, R loops, polycomb repressive complex 2
Introduction
The fragile X-related disorders are members of 20+ human genetic conditions known as the Repeat
Expansion Diseases (Mirkin, 2007). The disease-causing mutation in all cases is an expansion or
increase in the number of repeats in a specific tandem repeat tract. In the case of the fragile X-related
disorders, the repeat unit is CGG/CCG and the repeat tract is located in the 50 untranslated region
of the fragile X mental retardation 1 (FMR1) gene (Fu et al., 1991; Verkerk et al., 1991). The FMR1
gene encodes FMRP, a protein important for the regulation of translation of dendritic mRNAs in
response to synaptic activation (Weiler et al., 1997; Weiler and Greenough, 1999). Two different
pathological FMR1 allele size classes are distinguished. Premutation alleles have 55–200 repeats,
while alleles with >200 repeats are referred to as full mutation alleles. These two size classes are
distinguished because they confer risk of different clinical conditions. Carriers of premutation alleles
are at risk of an adult-onset neurodegenerative disorder known as fragile X-associated tremor/ataxia
syndrome (reviewed, in Hagerman, 2013). Female carriers are also at risk of fragile X-associated
primary ovarian insufficiency, a condition that is associated with fertility problems and an earlier
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than normal menopause (reviewed in, Sullivan et al., 2011; Sher-
man et al., 2014). In contrast, full mutation alleles are associated
with fragile X syndrome, the leading heritable cause of intellectual
disability and the major monogenic cause of autism (Oberle et al.,
1991; Fu et al., 1991; Verkerk et al., 1991).
Premutation and full mutation carrier symptoms are different,
in part, because the repeat has paradoxical effects on gene expres-
sion. Premutation alleles are hyper-expressed (Tassone et al.,
2000a) and disease symptoms result from the deleterious conse-
quences of high levels of expression of the transcript with large
numbers of CGG-repeats (reviewed, in Sellier et al., 2014). In
contrast, the symptoms of fragile X syndrome result from repeat-
mediated heterochromatin formation that causes transcriptional
silencing and a subsequent deficiency of FMRP (Pieretti et al.,
1991; Sutcliffe et al., 1992). Interestingly, it is becoming increas-
ingly apparent that heterochromatin formation is a common
feature of other Repeat Expansion Diseases that involve large
repeat tracts. This includes myotonic dystrophy type 1, Friedreich
ataxia and amyotrophic lateral sclerosis/frontotemporal dementia
(ALS/FTD; Otten and Tapscott, 1995; Steinbach et al., 1998; Her-
man et al., 2006; Greene et al., 2007; Belzil et al., 2013; Xi et al.,
2013).
How the repeats cause hyper-expression of premutation alleles
and silencing of full mutation alleles is not well understood. This
review will cover recent findings that suggest how the repeats are
able to have such different effects on gene expression.
The CGG-repeat Tract Forms Stable
Secondary Structures
The CGG-repeat that is present in both the FMR1 gene and its
transcript can form a variety of secondary structures. In vitro the
DNA repeats form a stem-loop/hairpin and a folded-hairpin-like
structure known as a G-tetraplex or quadruplex (Fry and Loeb,
1994; Kettani et al., 1995; Mitas et al., 1995; Usdin andWoodford,
1995; Patel et al., 2000). The hairpin contains amixture ofWatson-
Crick G:C base pairs and Hoogsteen G:G base pairs in a 2:1 ratio.
The quadruplex is stabilized primarily by G-quartets. The RNA
forms a similar set of structures (Handa et al., 2003; Zumwalt
et al., 2007; Malgowska et al., 2014). Similar structures are also
formed by many of the repeats responsible for other members of
the Repeat Expansion Disease family that show repeat-mediated
epigenetic changes (reviewed, in Usdin et al., 2015), and quadru-
plex formation has been reported for the very GC-rich ALS/FTD
repeats (Fratta et al., 2012; Reddy et al., 2013; Haeusler et al., 2014)
and the repeats responsible for progressive myoclonus epilepsy
type 1 (EPM1; Saha and Usdin, 2001). There is evidence for the
formation of stem-loop structures in vivo by the CGG-strand of
the fragile X repeat (Loomis et al., 2014) and the CAG- and CTG-
repeats responsible for diseases like Myotonic dystrophy type 1
and Huntington disease (Liu et al., 2010). Transient unpairing of
the repeat region during DNA replication, DNA repair or tran-
scription is thought to provide the opportunity for these structures
to form.
In addition to the above-mentioned structures, many disease-
associated repeats including the fragile X repeats (Groh et al.,
2014; Loomis et al., 2014), the Friedreich ataxia repeat (Groh
et al., 2014), the ALS/FTD repeat (Haeusler et al., 2014) and the
CTG/CAG-repeats responsible for a number of Repeat Expansion
Diseases (Lin et al., 2010) form stable R loops during transcrip-
tion. This R loop contains an RNA:DNA hybrid formed between
the nascent transcript and the transcribed strand. This leaves the
displaced non-template strand unpaired. Such R loops form in
regions with strand-asymmetry with regard to the distribution
of purines and pyrimidines, particularly when the pyrimidine-
rich strand is being transcribed. This R loop may be facilitated by
hairpin formation by the non-template strand that would reduce
the likelihood of reannealing of the duplex behind the advancing
transcription complex. Conversely, the persistence of this hybrid
might also favor the formation of the hairpin on the non-template
strand. R loops are the only structures identified to date that
are formed by all repeats that become heterochromatinized. In
bacteria and yeast R loops can also be formed in trans (e.g.,
by a distally transcribed mRNA) in the presence of RecA and
Rad51 respectively (Zaitsev and Kowalczykowski, 2000; Wahba
andKoshland, 2013), but evidence for suchR loops inmammalian
cells is lacking.
The number of repeats required to form an R loop on the
FMR1 gene and the timing of R loop formation is the subject of
some debate. One study suggests that they are only formed on full
mutation alleles relatively late in neuronal differentiation (Colak
et al., 2014), while other work suggests that R loops at the FMR1
locus also form on normal and premutation alleles in a number
of different cell types (Groh et al., 2014; Loomis et al., 2014).
This discrepancy may reflect differences in the stability of the
structures being measured. Formation of these structures in vivo
likely reflects some combination of the effect of repeat number,
transcription rate (Groh et al., 2014; Loomis et al., 2014) and the
expression of proteins that affect R loop stability (Colak et al.,
2014).
Repeat-mediated Epigenetic Effects on the
Premutation Allele
There is a direct relationship between the repeat number and
FMR1mRNA levels in humans andmice carrying the premutation
allele, such that premutation carriers have 2–10 times more FMR1
mRNA than individuals with repeat numbers in the normal range
(Tassone et al., 2000b; Entezam et al., 2007; Brouwer et al., 2008).
The increased RNA levels are the result of increased transcription
initiation rather than increased transcript stability (Tassone et al.,
2007). The promoter of premutation alleles is enriched for acety-
lated histones (Todd et al., 2010) and premutation alleles initiate
transcription from upstream start sites more frequently than is
seen in normal cells (Beilina et al., 2004). While hyper-expression
has not been reported for other Repeat Expansion Diseases, a
similar increased usage of more 50 start sites has been reported
in individuals with ALS (Sareen et al., 2013).
Very little is currently known about why premutation alleles are
overexpressed. CGG/CCG-repeats exclude nucleosomes in vitro
(Wang et al., 1996). In principle, this could result in the 50 end of
the FMR1 gene beingmore accessible to transcription factors or to
the transcription complex. However, to date there is no evidence
for repeat-mediated nucleosome exclusion on FMR1 alleles in
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vivo. The FMR1 promoter is very CpG rich and has many of
the hallmarks of a CpG-island promoter. CpG-island promoters
act as transcription-independent nucleation sites for the zinc fin-
ger CxxC domain-containing chromatin modifying proteins like
CxxC finger protein (CFP1; Thomson et al., 2010). CFP1 is a
component of the SET1A/B-containing methyltransferase com-
plex that facilitates H3K4 trimethylation (Clouaire et al., 2012),
a histone mark typically associated with the 50 ends of active
genes. This has led to the suggestion that such proteins provide a
self-reinforcing loop of unmethylatedCpG recognition and subse-
quent protection fromDNAmethylation (Blackledge et al., 2013).
In this view, hyper-expression of premutation alleles would be
related to the high density ofCpGs in the repeat that favors recruit-
ment of factors that inhibit gene silencing. Alternatively, proteins
like ATRX, a member of the SNF2 family of helicases/ATPases,
could also contribute to hyper-expression of premutation alleles.
ATRX colocalizes with G-rich regions that, like the FMR1 locus
(Fry and Loeb, 1994; Kettani et al., 1995; Usdin and Wood-
ford, 1995; Patel et al., 2000), have quadruplex-forming potential.
ATRX facilitates transcription elongation through these regions
by reducing transcription stalling (Levy et al., 2015).
R loops are a characteristic feature of unmethylated CpG-
islands where they have been suggested to play a role in preventing
gene silencing (Ginno et al., 2012). There is evidence to suggest
that R loops provide some protection from de novo methylation
byDNMT3B1, the primary de novoDNAmethyltransferase active
during early development (Ginno et al., 2012). How they do
so is currently unknown, but one possibility is that the single
stranded region of the R loop is a preferential binding site for
a number of epigenetic modifiers that are positive regulators of
transcription. These modifiers include members of the H3K4
methyltransferase family (Krajewski et al., 2005), whose activity
is thought to inhibit de novomethylation (Ooi et al., 2007). It also
includes the activation-induced cytosine deaminase (Chaudhuri
et al., 2003) that is thought to be important for DNA demethy-
lation (Popp et al., 2010). R loops may also be less capable of
properly binding nucleosomes (Dunn and Griffith, 1980) and
there is evidence to suggest that R loop formation causes chro-
mosome decondensation (Powell et al., 2013). R loops formed on
longer repeat tracts have been shown to extend further into the
flanking regions (Loomis et al., 2014). This could perhaps favor
transcription initiation by increasing the likelihood that promoter
melting will occur or by facilitating the binding of additional
transcription factors or chromatin modifiers to the promoter that
in turn promote transcription initiation.
Repeat-mediated Gene Silencing of Full
Mutation Alleles
In contrast to the marks of active chromatin found at the 50 end
of the FMR1 gene in premutation carriers, full mutation alleles
are hypermethylated and associated with hypoacetylated histones
(Chiurazzi et al., 1998, 1999; Coffee et al., 1999; Pietrobono et al.,
2002, 2005; Biacsi et al., 2008). They are also hypomethylated on
H3K4, enriched for marks typical of facultative heterochromatin
like H3K9me2 and H3K27me3, as well as histone modifications
associated with constitutive heterochromatin- H3K9me3 and
H4K20me3 (Kumari and Usdin, 2010). H3K9 dimethylation
has also been reported on Myotonic dystrophy type 1 alleles
(Cho et al., 2005), H3K9 trimethylation has been reported
on Friedreich ataxia alleles (Herman et al., 2006) and H3K9,
H3K27, and H4K20 trimethylation have been reported for
heterochromatinized ALS alleles (Belzil et al., 2013).
Treatment of fragile X patient cells with DNA methylation
inhibitors leads to partial gene reactivation that is not associated
with the loss of H3K9me2 or H3K9me3 (Kumari and Usdin,
2014). This suggests that DNA methylation occurs downstream,
or is independent of, the deposition of these chromatin mod-
ifications. This would be consistent with the observation that
in rare full mutation carriers in which gene silencing does not
occur, the FMR1 gene is enriched for H3K9me2 but shows no
CpG methylation (Tabolacci et al., 2008). The FMR1 gene can
also be reactivated by inhibition of Sirtuin 1 (SIRT1), the enzyme
responsible for the deacetylation of H3K9 and H4K16 on fragile
X alleles (Biacsi et al., 2008). Since DNA demethylation leads to
acetylation of H4K16 but not H3K9 (Biacsi et al., 2008), it would
be consistent with the idea that deacetylation of H3K9 precedes
DNA methylation while deacetylation of H4K16 is a late event in
the silencing process acting downstream of DNA methylation.
The earliest epigenetic change associated with silencing of the
fragile X allele is unknown. However, the fact that the histone
marks H3K9me3 and H4K20me3 show a peak of enrichment in
the region of the fragile X repeat would be consistent with the
idea that the repeats themselves are the site of nucleation for
the silencing process (Kumari and Usdin, 2010). FMR1 mRNA
knockdown blocks FMR1 gene silencing during neuronal differ-
entiation in fragile X embryonic stem cells (Colak et al., 2014)
and decreases the recruitment of polycomb repressive complex 2
(PRC2) to full mutation alleles that have been reactivated with
5-azadeoxycytidine (Kumari and Usdin, 2014). These findings
suggest that the FMR1 transcript plays a key role in gene silencing
by facilitating, either directly or indirectly, the recruitment of
repressive histone modifying complexes like PRC2.
The FMR1 transcript may facilitate gene silencing by recruiting
repressive histone modifiers as many long non-coding RNAs do.
Examples are knownwhere such RNA acts in cis or trans to recruit
PRC2 along with either the LSD1-CoREST complexes responsible
for H3K4me2 demethylation (Tsai et al., 2010), or the polycomb
repressive complex 1 (Yap et al., 2010), or the H3K9 methy-
lase G9a (Pandey et al., 2008). Long non-coding RNAs are also
involved in recruiting theH4K20 trimethylase Suv4-20h (Bierhoff
et al., 2014). The FMR1 transcript may be acting like these RNAs
to recruit repressors to the fragile X locus. These factors may
in turn act as a molecular scaffold to which other chromatin
modifiers bind to ultimately generate the histone modification
signature found on fragile X alleles (Kumari and Usdin, 2010).
Of interest in this regard is the fact that the Fmr1 transcript is
one of the transcripts most commonly associated with PRC2 in
normal mouse embryonic stem cells (Zhao et al., 2010). This
may be related to the ability of the 50 end of the transcript to
form stem-loop structures as assessed by the RNAfold algorithm
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). Such structures
are thought to be important for PRC2 binding (Zhao et al.,
Frontiers in Genetics | www.frontiersin.org June 2015 | Volume 6 | Article 1923
Usdin and Kumari Epigenetic dysregulation in the fragile X-related disorders
2008). The human FMR1 transcript is predicted to form similar
structures and may thus also recruit PRC2 to even to normal
and premutation alleles. However, not only would the amount of
PRC2 recruited to the FMR1 locus be limited by the relatively low
stability of the R loop on small repeat tracts, but any activity of
PRC2 would be also inhibited by the presence of nascent RNA
(Cifuentes-Rojas et al., 2014) or H3K36me3 (Schmitges et al.,
2011), a histone modification deposited co-transcriptionally by
the SETD2 protein. Even should some trimethylation of H3K27
occur, it’s spread would be limited by the high levels of H3K36me3
present in the region (Yuan et al., 2011).
In some cases targeting of the long non-coding RNA is thought
to be accomplished by a bivalent protein that binds both the RNA
and the target locus (Jeon and Lee, 2011), whilst in others the RNA
is tethered to its target gene via the formation of a RNA:DNA:DNA
triplex (Schmitz et al., 2010), or an RNA: DNA hybrid (Rinn and
Chang, 2012). Tethering via the formation of an RNA:RNAhybrid
has also been suggested (Rinn and Chang, 2012). Recruitment of
repressive complexes via an RNA:DNA hybrid may be relevant
for FMR1 gene silencing given the persistent R loop that is found
coincident with the repeat on FMR1 alleles (Groh et al., 2014;
Loomis et al., 2014) and the effect of R loop depletion on gene
silencing in fragile X ESC-derived neurons (Colak et al., 2014).
R loops have also been implicated in gene silencing in Friedreich
ataxia (Groh et al., 2014). In principle, either a cis or trans-
association of the transcript with the FMR1 locus could tether
the transcript to the promoter allowing it to recruit repressive
epigenetic modifiers like PRC2 that ultimately result in FMR1
gene silencing.
Gene silencing may also be triggered by the R loops themselves
in ways that are independent of the FMR1 transcript per se. The
free DNA strand in the fragile X R loop forms secondary struc-
tures (Loomis et al., 2014) that have been suggested to directly
recruit DNA methyltransferases (Smith et al., 1994). However,
our data suggests that DNA methylation is not the first step in
the fragile X gene silencing process (Biacsi et al., 2008; Kumari
and Usdin, 2014). Furthermore, Friedreich ataxia repeats do not
form such secondary structures and methylatable CpG residues
are not present in either the Friedreich ataxia repeats or the
myotonic dystrophy type 1 repeats. Thus if gene silencing in these
disorders has a common molecular basis, the use of this pathway
to initiate gene silencing seems unlikely. R loops also facilitate Pol
II pausing and termination (Skourti-Stathaki et al., 2011; Groh
et al., 2014). In the b-actin locus pausing results in the production
of an antisense transcript. The sense-antisense RNA pair leads to
the RNAi-dependent deposition ofH3K9me2 and the recruitment
of heterochromatin protein 1 (HP1; Skourti-Stathaki et al.,
2014). However, knockdown of Dicer, Ago1, and Ago2, genes
important for RNAi did not prevent FMR1 gene silencing in
neurons differentiated from fragile X embryonic stem cells (Colak
et al., 2014). This would seem to rule out a role for RNAi in
silencing of full mutation alleles, whether the RNAi is R loop-
mediated or mediated independently of R loops by the interaction
of the FMR1 sense and antisense transcript (Ladd et al., 2007) or
CGG-RNA hairpins that are Dicer substrates (Handa et al., 2003).
R loops are also prone to chromatin compaction via a H3S10
phosphorylation-dependent mechanism that is still unknown
(Castellano-Pozo et al., 2013). R loops have also been shown to
result in double-strand breaks (Sordet et al., 2010) that could lead
to the recruitment of a variety of epigenetic modifiers including
DNA methyltransferase 1 and SIRT1 (O’Hagan et al., 2008).
Unresolved Questions and Future
Directions
More work is needed before we understand the epigenetic reg-
ulation of the FMR1 gene. Until we do the question of why
shorter repeat tracts favor increased gene expression while longer
ones favor gene silencing remains unanswered. The paradoxical
effect of the repeats presumably reflects the equilibrium between
interactions of the repeat tract with factors that favor the accumu-
lation of positive chromatinmodifications and those that favor the
generation of repressive chromatin. For example, as illustrated in
Figure 1, smaller repeat tracts may be more likely to form RNA:
FIGURE 1 | Model for repeat-mediated gene dysregulation in fragile
X premutation and full mutation carriers. A metastable R loop formed by
the premutation allele would leave the non-template strand transiently
unpaired and thus able to recruit transcription activators that show a
preferential binding to single-stranded regions (Chaudhuri et al., 2003;
Krajewski et al., 2005). However, since the RNA:DNA hybrid is relatively short,
transcription termination is low and the transcript is not tethered to the FMR1
locus long enough to recruit transcriptional repressors that might bind the
hairpins formed by the 50 end of the FMR1 transcript. The net result is that the
premutation allele would be associated with elevated levels of active histone
modifications and thus hyper-expressed. In contrast, on full mutation alleles
the RNA:DNA hybrid is likely to be more stable . It may thus be able to
effectively recruit repressive chromatin modifiers to the 50 end of the FMR1
gene that result in the deposition of repressive histone marks. The hybrid may
also be long enough to cause significant transcription termination
(Skourti-Stathaki et al., 2011; Groh et al., 2014). This would result in a drop in
the levels of co-transcriptionally deposited active chromatin modifications.
This could result in the loss of the protective effect that these histone marks
provide against the deposition of repressive histone marks (Schmitges et al.,
2011; Yuan et al., 2011). The non-template strand in the R loop may also be
more likely to form secondary structures and thus less likely to bind
transcription activators with a preference for single-stranded regions. The net
result would be transcriptional silencing of the full mutation allele.
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DNA hybrids that have a short half-life and that may leave the
non-template strand single-stranded just long enough to bind
transcriptional activators or DNA demethylases that have a pref-
erence for single-stranded regions. In contrast, longer repeat tracts
would be more likely to form stable RNA:DNA hybrids that were
better able to recruit complexes like G9a and PRC2 that deposit
repressive chromatin marks. The longer hybrids may also be
more prone to transcription termination that could result in the
loss of H3K36me3 and H3K4me3 and thus the protection from
encroachment of repressive chromatin (Yuan et al., 2011). The
non-template strand may also be more likely to form stable sec-
ondary structures that reduce binding of transcription activators
with a preference for single-stranded regions.
In addition, while the idea that a co-transcriptionally formed R
loop is responsible for silencing is appealing, the ability of siRNA
or shRNA to the FMR1 transcript to reduce repression of fragile
X alleles (Colak et al., 2014; Kumari and Usdin, 2014) suggests
that the situation may not be quite so simple. Despite reports
of active RNAi factors in the nucleus (Gagnon et al., 2014), the
ability of RNAi to deplete RNAs that are exclusively nuclear is
still controversial. An alternative explanation consistent with the
available data is that the R loop forms in trans from a transcript
that has transitioned through the cytoplasm. If so, then R loop
formation may be facilitated by the ability of the CGG-strand of
the DNA to form secondary structures during transcription thus
leaving the CCG-DNA strand free.
The question of the timing of gene silencing in the fragile X
embryo is also still unresolved. This is significant for our under-
standing as to whether FMRP is present during early embryonic
development in individuals with fragile X syndrome. Silencing has
been reported to be a relatively late event in embryonic develop-
ment, occurring >45 days after differentiation of neurons from
embryonic stem cells is initiated (Colak et al., 2014). However,
in many fragile X ESC lines significant gene silencing has already
occurred (Avitzour et al., 2014). This includes the ESC lines used
inColak et. al. study as evidenced by the fact that a significant frac-
tion of the fragile X alleles in these cells are resistant to digestion by
Eag I, a methylation-sensitive restriction enzyme (Supplementary
Figure 1; Colak et al., 2014). How much silencing occurs in the
early embryo and how this silencing compares to the silencing
observed in neurons are thus important open questions.
There is also the question of what, if anything, can be done
to prevent or reverse the repeat-mediated epigenetic changes in
premutation and full mutation carriers. A number of compounds
that are able to inhibit repressive epigenetic modifications are
already in clinical trials for treatment of Friedreich ataxia. It is of
interest that Vitamin B3 (nicotinamide), an inhibitor of SIRT1, has
shown promise in Phase I trials for Friedreich ataxia (Libri et al.,
2014). The identification of FMR1 transcription as the trigger
for silencing opens up a whole new potential approach to gene
reactivation. A small molecule that blocks hybrid formation and
prevents silencing (Colak et al., 2014) was unable to reactivate a
silenced allele. However, it may able to do so in combination with
other epigenetic modifiers. Of course, any benefit to be gained
by reactivation of the fragile X allele would have to be offset by
the risk posed by expression of FMR1 mRNA with long CGG-
repeat tracts (Loesch et al., 2012). It may also be possible to
ameliorate the symptoms seen in premutation carriers by using
epigenetic modifying compounds that reduce the FMR1 hyper-
expression. For example, since SIRT1 is involved in down regu-
lation of FMR1 expression, SIRT1 activators may help normalize
the levels of the toxic transcript produced from premutation
alleles.
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